To reduce dependency on protein by valorizing all side streams of salmon rich value chains
Biomega aims to naturally and gently transfer fresh and pure Norwegian salmon parts into premium food grade ingredients. Trying to seek potential alternative utilisation of salmon offcuts for peptides and oil for human consumption (health nutrition, sports nutrition, nutraceuticals) and as pet feed. Biomega was founded on the premise of advance biotechnology to valorize the full nutritional and functional value of side streams from salmon industry
In their modern biorefineries in Noway and Denmark Biomega turn food-grade fresh marine raw materials into premium ingredients. Sophisticated biorefining processes ensure careful separation of nutritional components. The technology deployed is not only limited to salmon, but also includes other marine species such as cod, pelagic and mesopelagic, as well as chicken and other types of poultry and is part of the circular economy strategy. Bio mega aspires to become the leading partner for innovative high-quality ingredients to the health and nutrition industry.
The global salmon market size was valued at $50,170.0 million in 2020, and is estimated to reach $76,145.3 million by 2028, registering a CAGR of 3.7% from 2021 to 2028
Reducing the distance between ingredient production and the raw material by locating production facilities next to raw material providers. This is not only good for the end product, but also the environment by reducing the carbon footprint in their supply chain
Their process is not only limited to salmon but also applied to a wide range of marine raw materials, including cod, pelagic and mesopelagic, thus creating immense socioeconomical boost to the marine harvesters
Salmon fish farmers, Technology providers, End users (nutraceutical)
Fresh and pure Norwegian salmon parts
9
Biomega
Enzymatic hydrolysis
Biomega Salme peptides (nutraceutical), pet feed
Flagship plant
Norway, Denmark
2000